WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:WGBS
CUSIPN/A
Phone+1-510-6514450
Debt
Debt-to-Equity Ratio1.90
Current Ratio1.82
Quick Ratio1.53
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-153.30%
Return on Equity-463.27%
Return on Assets-111.39%
Miscellaneous
Employees54
Outstanding Shares3,790,000
Market Cap$26.12 million
WaferGen Bio-systems (NASDAQ:WGBS) Frequently Asked Questions
What is WaferGen Bio-systems' stock symbol?
WaferGen Bio-systems trades on the NASDAQ under the ticker symbol "WGBS."
How were WaferGen Bio-systems' earnings last quarter?
WaferGen Bio-systems, Inc. (NASDAQ:WGBS) released its earnings results on Tuesday, August, 9th. The medical research company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.18) by $0.08. The medical research company earned $2.50 million during the quarter, compared to analyst estimates of $2.60 million. WaferGen Bio-systems had a negative net margin of 153.30% and a negative return on equity of 463.27%. View WaferGen Bio-systems' Earnings History.
How do I buy shares of WaferGen Bio-systems?
Shares of WGBS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WaferGen Bio-systems' stock price today?
One share of WGBS stock can currently be purchased for approximately $6.90.
How big of a company is WaferGen Bio-systems?
WaferGen Bio-systems has a market capitalization of $26.12 million. WaferGen Bio-systems employs 54 workers across the globe.
What is WaferGen Bio-systems' official website?
How can I contact WaferGen Bio-systems?
WaferGen Bio-systems' mailing address is 34700 Campus Dr, FREMONT, CA 94555-3612, United States. The medical research company can be reached via phone at +1-510-6514450.
MarketBeat Community Rating for WaferGen Bio-systems (NASDAQ WGBS)
MarketBeat's community ratings are surveys of what our community members think about WaferGen Bio-systems and other stocks. Vote "Outperform" if you believe WGBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WGBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
